Harm Reduction Therapeutics
Manufacturing · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4800 Montgomery Ln Ste 400, Bethesda, Ma...Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Harm Reduction Therapeutics
Harm Reduction Therapeutics, Inc. is a non-profit pharmaceutical company dedicated to making lifesaving overdose reversal medication affordable and accessible. They manufacture RiVive, a 3 mg nasal naloxone product designed for the emergency treatment of opioid overdose. Their mission focuses on compassion and support for individuals at risk of overdose, including first-time drug users, concerned family members, and harm reduction program supporters. By offering RiVive at a low price, they aim to save as many lives as possible that would otherwise be lost to opioid overdose.Explore more
Harm Reduction Therapeutics Org Chart
CT
Director, Sales & Marketing
PK
Director, Sales & Marketing
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Harm Reduction Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Harm Reduction Therapeutics has new funding data
Check if Harm Reduction Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Harm Reduction Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Harm Reduction Therapeutics is spiking on competitors!
Click to see if Harm Reduction Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Harm Reduction Therapeutics launches new products
Earning: See what the market has to say on Harm Reduction Therapeutics recently announced quarterly report
Harm Reduction Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Harm Reduction Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Harm Reduction Therapeutics
Compare insights from companies similar to Harm Reduction Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Harm Reduction Therapeuti...
<$5M
11-50
Private
-
2017
RM
Richard MannionPharmaceutical Development Head
Company Profile Activity
Activity Insights
Harm Reduction Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Harm Reduction Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Harm Reduction Therapeutics.
Harm Reduction Therapeutics Tech Stack
A closer look at the technologies used by Harm Reduction Therapeutics
See more technologies
Harm Reduction Therapeutics News & Media
FDA Approves Harm Reduction Therapeutics’ Over-the-Counter Opioid Overdose Reversal Medication
STAMFORD, Conn.--(BUSINESS WIRE)--FDA has approved Harm Reduction Therapeutics’ (HRT) new drug application for RiVive™ (Naloxone HCl Nasal Spray 3 mg) to be available over the counter (OTC) for the emergency treatment of opioid overdose. Naloxone is an opioid antagonist rescue medication used to reverse the effects of a life-threatening opioid overdose. As an independent, 501(c)(3) non-profit pharmaceutical company, HRT’s mission is to prevent opioid overdose deaths by making low-cost intranasaFDA Approval of RiVive(TM) Is a Critical Milestone in Making Emergency Treatment of Opioid Overdose More Widely Available
RiVive™, a naloxone nasal spray that is easy to use, will be available over-the-counter Unlike other opioid overdose products, Harm Reduction Therapeutics will make RiVive™, which can save lives, available for free or at low breakeven costPittsburgh, Pennsylvania--(Newsfile Corp. - July 28, 2023) - Harm Reduction Therapeutics (HRT), Inc., a nonprofit pharmaceutical company, announced today that FDA has approved OTC RiVive™ (naloxone HCl nasal spray 3 mg) for the emergency treatment of opioid...Harm Reduction Therapeutics and Catalent Sign Commercial Supply Agreement for Naloxone Nasal Spray to Reverse Opioid Overdoses
Harm Reduction Therapeutics, a 501(c)(3) non-profit pharmaceutical company whose mission is to prevent opioid overdose deaths by making low-cost naloxone available to everyone, and Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the signing of a commercial supply agreement. Under its terms, Catalent will manufacture Harm Reduction Therapeutics’ naloxone nasal spray, RiVive™ (3.0 mg), for the emergency treatment of known orHarm Reduction Therapeutics to Receive Additional Funding for its Low-Cost Over-the-Counter Opioid Overdose Reversal Medication from Purdue Pharma
STAMFORD, Conn.--(BUSINESS WIRE)--The Bankruptcy Court today approved Purdue Pharma providing Harm Reduction Therapeutics (HRT) up to $9 million in additional financial support to fund commercial readiness for HRT’s low-cost over-the-counter (OTC) intranasal naloxone spray, tradename RiVive.* Naloxone is an opioid antagonist rescue medication used to reverse the effects of a life-threatening opioid overdose.1 HRT is an independent, 501(c)(3) non-profit pharmaceutical company whose sole mission
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Harm Reduction Therapeutics
Sign Up For FreeTo access detailed company insights
Harm Reduction Therapeutics, Inc. is a non-profit pharmaceutical company dedicated to making lifesaving overdose reversal medication affordable and accessible. They manufacture RiVive, a 3 mg nasal naloxone product designed for the emergency treatment of opioid overdose. Their mission focuses on compassion and support for individuals at risk of ove... Read More
